SCHEMBL2276486

SCHEMBL2276486

CC(C)(C)OC(=O)C1(c2ccccc2)C=CC=CC1N

nearest known ligand 0.33

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RORC P51449 3/20 0.33
KDM1A O60341 1/20 0.33
HTT P42858 1/20 0.33
NFKB1 P19838 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32
ABCB1 P08183 1/20 0.32
POLB P06746 1/20 0.31
GPR55 Q9Y2T6 1/20 0.31
GPR119 Q8TDV5 1/20 0.31
GRM6 O15303 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
ALDH1A1 P00352 1/20 0.30
TSHR P16473 1/20 0.30
HSD17B10 Q99714 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
SLC7A5 Q01650 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2268370 0.83 ELANE (0.46) KDM1A
SCHEMBL4091330 0.77 SLC6A4 (0.38) POLBSMN1; SMN2ALDH1A1
SCHEMBL4225392 0.69 HTT (0.40) HTTSMN1; SMN2MEN1KMT2AALDH1A1
Urea SCHEMBL10593912 0.67 MAOB (0.32) POLBTSHRHSD17B10TDP1
SCHEMBL20378032 0.67 ALDH1A1 (0.33) HTTSMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL8469874 0.66 AKR1C1 (0.35) HTTSMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL8649514 0.66 BCHE (0.38) RORCHTTMEN1KMT2AALDH1A1
SCHEMBL27621152 0.66 LMNA (0.33) HTTPOLBSMN1; SMN2TSHRHSD17B10
SCHEMBL7379460 0.66 MEN1 (0.38) RORCGPR119GRM6MEN1KMT2A
Hydrochloric Acid SCHEMBL28568646 0.65 HSD11B1 (0.35) HTTKMT2AALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7999132-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2011-08-16 US disclosed
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF MMP13, MMP26, MMP11 RORC 1713/4885KDM1A 443/4885HTT 3716/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.